Open AccessNewer P2Y 12 Inhibitors: How Does the Interventional Cardiologist Choose?
Author(s) -
Shavelle David M.
Publication year - 2016
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.004460
Subject(s) - medicine , interventional cardiology , cardiology , medical physics , intensive care medicine
Dual antiplatelet therapy remains the cornerstone of the medical management of patients with acute coronary syndrome (ACS). In ACS patients receiving a coronary stent, the combination of aspirin and a P2Y12 inhibitor reduces rates of stent thrombosis and major adverse cardiovascular events. Given